[The surgical management of recurrent urological malignancies after primary ablative therapy].
This literature review highlights the surgical management of recurrent urological malignancies after primary ablative therapy. In particular, recurrent nonseminomatous germ cell tumours (NSGCT) post-chemotherapy, recurrent bladder cancer post-cystectomy, loco-regional recurrence of prostate cancer after radiotherapy, and loco-regional recurrence of renal cell carcinoma after radical nephrectomy. The indications, operative technique, complications and outcomes of each malignancy are discussed.
Galiano
Marc
M
Institut mutualiste Montsouris, Université René-Descartes Paris V, 42 boulevard Jourdan, 75674 Paris cedex 14.
Dugardin
Fabrice
F
Rozet
François
F
Cathelineau
Xavier
X
Vallancien
Guy
G
D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000601:surgery; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000601:surgery*; D018365:Neoplasm, Residual; D009392:Nephrectomy; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000601:surgery; D012186:Retroperitoneal Neoplasms / Q000556:secondary / Q000601:surgery; D016879:Salvage Therapy; D013736:Testicular Neoplasms / Q000601:surgery; D014516:Ureteral Neoplasms / Q000556:secondary / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000601:surgery; D014571:Urologic Neoplasms / Q000601:surgery*